首页> 美国卫生研究院文献>Pharmaceutics >Polymer–Lipid Pharmaceutical Nanocarriers: Innovations by New Formulations and Production Technologies
【2h】

Polymer–Lipid Pharmaceutical Nanocarriers: Innovations by New Formulations and Production Technologies

机译:聚合物 - 脂质药物纳米载体:新配方和生产技术的创新

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Some issues in pharmaceutical therapies such as instability, poor membrane permeability, and bioavailability of drugs can be solved by the design of suitable delivery systems based on the combination of two pillar classes of ingredients: polymers and lipids. At the same time, modern technologies are required to overcome production limitations (low productivity, high energy consumption, expensive setup, long process times) to pass at the industrial level. In this paper, a summary of applications of polymeric and lipid materials combined as nanostructures (hybrid nanocarriers) is reported. Then, recent techniques adopted in the production of hybrid nanoparticles are discussed, highlighting limitations still present that hold back the industrial implementation.
机译:药物疗法中的一些问题如不稳定,膜渗透性,药物的生物利用度,可以通过基于两种柱子的成分组合的合适的递送系统来解决:聚合物和脂质。与此同时,现代技术必须克服生产限制(低生产率,高能耗,昂贵的设置,长的过程时间)来通过工业水平。本文报道,报道了聚合物和脂质材料组合为纳米结构(杂交纳米载体)的应用概述。然后,讨论了杂交纳米颗粒生产中采用的最近技术,突出了仍存在抵押工业实施的局限性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号